Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Cavaletti

Showing results (191-200 of 261) with videos related to

Pageof 27
Sort By:
Neurotoxicity Research|October 31, 2009
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing ratsIlaria Cervellini, Ezia Bello, Roberta Frapolli, et al.
Journal of the Peripheral Nervous System : JPNS|September 18, 2007
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity ScaleGuido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicityRoberto Bianchi, Michael Brines, Giuseppe Lauria, et al.
Expert Review of Neurotherapeutics|December 13, 2021
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinionSusanna B Park, Stefano Tamburin, Angelo Schenone, et al.
The American Journal of Pathology|October 29, 2013
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cellsMarina Figliuzzi, Roberto Bianchi, Cristina Cavagnini, et al.
Critical Reviews in Oncology/Hematology|December 30, 2021
Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: Systematic review and evidence-based recommendationsStefano Tamburin, Susanna B Park, Angelo Schenone, et al.
Cell Cycle (Georgetown, Tex.)|December 17, 2013
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathyCristina Meregalli, Alessia Chiorazzi, Valentina A Carozzi, et al.
Frontiers in Pharmacology|June 4, 2019
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic CancerAnna Tesei, Michela Cortesi, Sara Pignatta, et al.
Nursing Research|December 27, 2018
Global Transcriptomic Profile of Dorsal Root Ganglion and Physiological Correlates of Cisplatin-Induced Peripheral NeuropathySherrie Lessans, Cameron B Lassiter, Valentina Carozzi, et al.
Neurology|July 28, 2017
Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendationsJennifer S Gewandter, Roy Freeman, Rachel A Kitt, et al.
Pageof 27

Showing results (191-200 of 261) with videos related to

Sort By:
Pageof 27
Neurotoxicity Research|October 31, 2009
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing ratsIlaria Cervellini, Ezia Bello, Roberta Frapolli, et al.
Journal of the Peripheral Nervous System : JPNS|September 18, 2007
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity ScaleGuido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicityRoberto Bianchi, Michael Brines, Giuseppe Lauria, et al.
Expert Review of Neurotherapeutics|December 13, 2021
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinionSusanna B Park, Stefano Tamburin, Angelo Schenone, et al.
The American Journal of Pathology|October 29, 2013
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cellsMarina Figliuzzi, Roberto Bianchi, Cristina Cavagnini, et al.
Critical Reviews in Oncology/Hematology|December 30, 2021
Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: Systematic review and evidence-based recommendationsStefano Tamburin, Susanna B Park, Angelo Schenone, et al.
Cell Cycle (Georgetown, Tex.)|December 17, 2013
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathyCristina Meregalli, Alessia Chiorazzi, Valentina A Carozzi, et al.
Frontiers in Pharmacology|June 4, 2019
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic CancerAnna Tesei, Michela Cortesi, Sara Pignatta, et al.
Nursing Research|December 27, 2018
Global Transcriptomic Profile of Dorsal Root Ganglion and Physiological Correlates of Cisplatin-Induced Peripheral NeuropathySherrie Lessans, Cameron B Lassiter, Valentina Carozzi, et al.
Neurology|July 28, 2017
Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendationsJennifer S Gewandter, Roy Freeman, Rachel A Kitt, et al.
Pageof 27